詳細検索

詳細検索

詳細検索

お問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2026/11/02 10:26

158.80 円

177.64 円

215.29 円

医療 市場調査レポート

このリストでは医療市場に関する調査レポートを新刊順に紹介しています。
例えば、医療IT、 医療/ヘルスケア、プライマリケア、医療機器といった分野の動向に関する調査レポート (技術動向、市場規模予測)を紹介しています。

ビデオ監視市場:製品別(ハードウェア(カメラ、ストレージデバイス、モニター)、ソフトウェア(ビデオ解析、VMS)、サービス(VSaaS))、システム別(IP、アナログ、ハイブリッド)、業種別、地域別(北米、欧州、APAC、RoW)-2027年までの世界市場予測
ビデオ監視市場:製品別(ハードウェア(カメラ、ストレージデバイス、モニター)、ソフトウェア(ビデオ解析、VMS)、サービス(VSaaS))、システム別(IP、アナログ、ハイブリッド)、業種別、地域別(北米、欧州、APAC、RoW)-2027年までの世界市場予測
Video Surveillance Market by Offering (Hardware (Camera, Storage Device, Monitor), Software (Video Analytics, VMS), Service (VSaaS)), System (IP, Analog, Hybrid), Vertical and Geography (North America, Europe, APAC, RoW) - Global Forecast to 2027
価格 US$ 4,950 |  MarketsandMarkets | 2022年8月
ビデオ監視市場は、2022年の487億米ドルから2027年には764億米ドルに達すると予測されており、予測期間中のCAGRは9.4%と予想されています。IoTによりインターネット上でのデータの送受信がよりシンプルになり、スマートシティにおけるビデオ監視の利用が促進されています。I…
このレポートの詳細ページはこちら
DNAシーケンシング 2023-2033年:技術、市場、予測
DNAシーケンシング 2023-2033年:技術、市場、予測
DNA Sequencing 2023-2033: Technologies, Markets, and Forecasts
価格はお問い合わせください |  IDTechEx | 2022年8月
この調査レポートでは、DNAシーケンサ業界を取り上げ、関連する主要技術や市場について詳細に調査・分析しています。 主な掲載内容(目次より抜粋) DNAシーケンシングの技術 DNAシーケンシング 市場 予測 Report Summary This re…
このレポートの詳細ページはこちら
ウィメンズヘルス治療薬の世界市場 2022-2026
ウィメンズヘルス治療薬の世界市場 2022-2026
Global Women's Health Therapeutics Market 2022-2026
価格 US$ 2,500 |  TechNavio | 2022年8月
女性の健康治療薬の世界市場2022-2026年 Technavioは女性の健康治療薬市場を監視しており、2022-2026年の間に303億5000万ドルの成長が見込まれ、予測期間中にCAGR 5.74%で加速しています。女性の健康治療薬市場に関する当レポートでは、全体的な分析、市場規模と予測、動向、…
このレポートの詳細ページはこちら
皮膚科用内視鏡機器の世界市場 2022-2026
皮膚科用内視鏡機器の世界市場 2022-2026
Global Dermatology Endoscopy Devices Market 2022-2026
価格 US$ 2,500 |  TechNavio | 2022年8月
皮膚科内視鏡検査装置の世界市場 2022-2026 年 Technavioは皮膚科内視鏡検査装置市場を監視しており、2022-2026年の間に1億5212万ドルの成長が見込まれ、予測期間中にCAGR 9.35%で加速しています。当レポートでは、皮膚科向け内視鏡検査装置市場の全体分析、市場規模と予測、…
このレポートの詳細ページはこちら
Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
価格 US$ 3,500 |  Global Markets Direct | 2022年8月
Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Coagulation Factor XI (Plasma Thromboplastin Ante…
このレポートの詳細ページはこちら
Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
価格 US$ 3,500 |  Global Markets Direct | 2022年8月
Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Estrogen Receptor Beta (ER Bet…
このレポートの詳細ページはこちら
Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
価格 US$ 3,500 |  Global Markets Direct | 2022年8月
Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recen…
このレポートの詳細ページはこちら
Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
価格 US$ 3,500 |  Global Markets Direct | 2022年8月
Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Retinoic Acid Receptor…
このレポートの詳細ページはこちら
Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
価格 US$ 3,500 |  Global Markets Direct | 2022年8月
Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Placenta Growth Factor (Vascular Endothelial G…
このレポートの詳細ページはこちら
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
価格 US$ 2,000 |  Global Markets Direct | 2022年8月
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide…
このレポートの詳細ページはこちら
Atherosclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Atherosclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
価格 US$ 2,500 |  Global Markets Direct | 2022年8月
Atherosclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Atherosclerosis - Drugs In Development, 2022, provid…
このレポートの詳細ページはこちら
Bronchiectasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Bronchiectasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
価格 US$ 2,000 |  Global Markets Direct | 2022年8月
Bronchiectasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bronchiectasis - Drugs In Development, 2022, provides…
このレポートの詳細ページはこちら
Cataract Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Cataract Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
価格 US$ 2,000 |  Global Markets Direct | 2022年8月
Cataract Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cataract - Drugs In Development, 2022, provides an overview…
このレポートの詳細ページはこちら
Ureter Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Ureter Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
価格 US$ 2,000 |  Global Markets Direct | 2022年8月
Ureter Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ureter Cancer - Drugs In Development, 2022, provides a…
このレポートの詳細ページはこちら
Basal Cell Carcinoma (Basal Cell Epithelioma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Basal Cell Carcinoma (Basal Cell Epithelioma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
価格 US$ 2,000 |  Global Markets Direct | 2022年8月
Basal Cell Carcinoma (Basal Cell Epithelioma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Basal Cell Carcinoma (…
このレポートの詳細ページはこちら
Oropharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Oropharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
価格 US$ 2,000 |  Global Markets Direct | 2022年8月
Oropharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Oropharyngeal Cancer - Drugs In Development, 20…
このレポートの詳細ページはこちら
Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
価格 US$ 2,500 |  Global Markets Direct | 2022年8月
Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer - Drugs In Development, 20…
このレポートの詳細ページはこちら
Fallopian Tube Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Fallopian Tube Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
価格 US$ 2,500 |  Global Markets Direct | 2022年8月
Fallopian Tube Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fallopian Tube Cancer - Drugs In Development, …
このレポートの詳細ページはこちら
Gastric Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Gastric Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
価格 US$ 2,500 |  Global Markets Direct | 2022年8月
Gastric Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastric Cancer - Drugs In Development, 2022, provides…
このレポートの詳細ページはこちら
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
価格 US$ 2,000 |  Global Markets Direct | 2022年8月
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Adrenocortical Carc…
このレポートの詳細ページはこちら
カテゴリ別にレポートを見る

ページTOPに戻る